Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paras Shah

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
The Journal of Urology|December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival OutcomesMohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
JCI Insight|December 20, 2019
Non-fibro-adipogenic pericytes from human embryonic stem cells attenuate degeneration of the chronically injured mouse muscleGina M Mosich, Regina Husman, Paras Shah, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 14, 2019
Aged Mice Demonstrate Greater Muscle Degeneration of Chronically Injured Rotator CuffAbhinav K Sharma, Brandon Levian, Paras Shah, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
Urologic Oncology|December 5, 2019
Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potentialNikhil Waingankar, Alberto Martini, Luke Griffiths, et al.
Cancers|February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder CancerAbby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Urology|June 23, 2026
A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the BladderDaniel S Roberson, Michael K Wang, Matthew T McLeay Ii, et al.
European Urology|May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter AnalysisDaniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
Life (Basel, Switzerland)|August 29, 2024
Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate CancerParas Shah, William R Taylor, Brianna J Negaard, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
BJU International|November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
The Journal of Urology|December 2, 2024
Intraoperative Tranexamic Acid in Radical Cystectomy: Impact on Bleeding, Thromboembolism, and Survival OutcomesMohamed E Ahmed, Jack R Andrews, Ahmed M Mahmoud, et al.
JCI Insight|December 20, 2019
Non-fibro-adipogenic pericytes from human embryonic stem cells attenuate degeneration of the chronically injured mouse muscleGina M Mosich, Regina Husman, Paras Shah, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|September 14, 2019
Aged Mice Demonstrate Greater Muscle Degeneration of Chronically Injured Rotator CuffAbhinav K Sharma, Brandon Levian, Paras Shah, et al.
European Urology Open Science|February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical CystectomyJoep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
Urologic Oncology|December 5, 2019
Weighted Gleason Grade Group (WGGG): A new prostate cancer biopsy reporting system with prognostic potentialNikhil Waingankar, Alberto Martini, Luke Griffiths, et al.
Cancers|February 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder CancerAbby L Grier, Jeffrey Y Zhong, Spyridon Basourakos, et al.
Urology|June 23, 2026
A Pilot Study of Ex-vivo High Frequency Ultrasound and Core Needle Biopsy to Improve Clinical Tumor Staging of Cancer of the BladderDaniel S Roberson, Michael K Wang, Matthew T McLeay Ii, et al.
European Urology|May 27, 2025
Consolidative Surgery for Advanced Urothelial Carcinoma Following Induction Enfortumab Vedotin and/or Immune Checkpoint Inhibitor Therapy: A Multicenter AnalysisDaniel S Roberson, Vidit Sharma, Stephen A Boorjian, et al.
Life (Basel, Switzerland)|August 29, 2024
Methylated DNA Markers in Voided Urine for the Identification of Clinically Significant Prostate CancerParas Shah, William R Taylor, Brianna J Negaard, et al.
Pageof 7